347 related articles for article (PubMed ID: 27489070)
1. New use for an old drug: oral ketamine for treatment-resistant depression.
Swiatek KM; Jordan K; Coffman J
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27489070
[TBL] [Abstract][Full Text] [Related]
2. Ketamine for Treatment-Resistant Depression: A Gateway to Novel Treatment Approaches.
Limandri BJ
J Psychosoc Nurs Ment Health Serv; 2018 Oct; 56(10):11-14. PubMed ID: 30278095
[TBL] [Abstract][Full Text] [Related]
3. Ketamine-induced affective switch in a patient with treatment-resistant depression.
Banwari G; Desai P; Patidar P
Indian J Pharmacol; 2015; 47(4):454-5. PubMed ID: 26288483
[TBL] [Abstract][Full Text] [Related]
4. Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion.
Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP
J Affect Disord; 2018 Dec; 241():1-7. PubMed ID: 30081380
[TBL] [Abstract][Full Text] [Related]
5. Ketamine for Treatment-Resistant Depression: a New Advocate.
Pérez-Esparza R
Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression.
Albott CS; Lim KO; Forbes MK; Erbes C; Tye SJ; Grabowski JG; Thuras P; Batres-Y-Carr TM; Wels J; Shiroma PR
J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29727073
[TBL] [Abstract][Full Text] [Related]
7. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
[TBL] [Abstract][Full Text] [Related]
8. Low-dose ketamine for treatment resistant depression in an academic clinical practice setting.
Feifel D; Malcolm B; Boggie D; Lee K
J Affect Disord; 2017 Oct; 221():283-288. PubMed ID: 28666206
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
[TBL] [Abstract][Full Text] [Related]
10. Ketamine for the treatment of depression.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2013 Jan; 51(1):11-4. PubMed ID: 23413455
[TBL] [Abstract][Full Text] [Related]
11. Ketamine for depression.
Jelen LA; Stone JM
Int Rev Psychiatry; 2021 May; 33(3):207-228. PubMed ID: 33569971
[TBL] [Abstract][Full Text] [Related]
12. How does ketamine elicit a rapid antidepressant response?
Kavalali ET; Monteggia LM
Curr Opin Pharmacol; 2015 Feb; 20():35-9. PubMed ID: 25462290
[TBL] [Abstract][Full Text] [Related]
13. Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.
Kadriu B; Musazzi L; Henter ID; Graves M; Popoli M; Zarate CA
Int J Neuropsychopharmacol; 2019 Feb; 22(2):119-135. PubMed ID: 30445512
[TBL] [Abstract][Full Text] [Related]
14. Is Ketamine the Future Clozapine for Depression? A Case Series and Literature Review on Maintenance Ketamine in Treatment-resistant Depression With Suicidal Behavior.
Chan LF; Eu CL; Soh SY; Maniam T; Shahidii Kadir Z; Chong BTW; Loo JL; Sharip S; Wong VCW; Loo TH; Ng YP; Kahn DA
J Psychiatr Pract; 2018 Jul; 24(4):279-291. PubMed ID: 30427812
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study.
Vidal S; Gex-Fabry M; Bancila V; Michalopoulos G; Warrot D; Jermann F; Dayer A; Sterpenich V; Schwartz S; Vutskits L; Khan N; Aubry JM; Kosel M
J Clin Psychopharmacol; 2018 Dec; 38(6):590-597. PubMed ID: 30346333
[TBL] [Abstract][Full Text] [Related]
16. Intravenous ketamine for treatment-resistant major depressive disorder.
Covvey JR; Crawford AN; Lowe DK
Ann Pharmacother; 2012 Jan; 46(1):117-23. PubMed ID: 22190250
[TBL] [Abstract][Full Text] [Related]
17. Esketamine: a glimmer of hope in treatment-resistant depression.
Kaur U; Pathak BK; Singh A; Chakrabarti SS
Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):417-429. PubMed ID: 31745646
[TBL] [Abstract][Full Text] [Related]
18. Ketamine for treatment-resistant unipolar depression: current evidence.
Mathew SJ; Shah A; Lapidus K; Clark C; Jarun N; Ostermeyer B; Murrough JW
CNS Drugs; 2012 Mar; 26(3):189-204. PubMed ID: 22303887
[TBL] [Abstract][Full Text] [Related]
19. The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
Li CT; Chen MH; Lin WC; Hong CJ; Yang BH; Liu RS; Tu PC; Su TP
Hum Brain Mapp; 2016 Mar; 37(3):1080-90. PubMed ID: 26821769
[TBL] [Abstract][Full Text] [Related]
20. [Effect of sub-anaesthetic doses of ketamine in the postoperative period in a patient with uncontrolled depression].
Cortiñas-Saenz M; Alonso-Menoyo MB; Errando-Oyonarte CL; Alférez-García I; Carricondo-Martínez MA
Rev Esp Anestesiol Reanim; 2013 Feb; 60(2):110-3. PubMed ID: 22818586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
